Practices for Managing Excessive Daytime Sleepiness in Patients with Narcolepsy and Obstructive Sleep Apnea
August 23, 2020
Practices for Managing Excessive Daytime Sleepiness in Patients with Narcolepsy and Obstructive Sleep Apnea
CME 0.75 Credits
Medical Cannabis The Science. The Research. The Risk.
February 28, 2020
“Medical Cannabis: The science. The research. The risks.” is a full spectrum education program for the medical community. This conference held on November 15th, 2019 in New York focuses on the scientific and legal knowledge of healthcare professionals (physicians, pharmacists, physician assistants, nurse practitioners) and medical legal professionals. Anyone who wants to learn more about the science and potential liability surrounding cannabis will benefit from it.
CE | CME 5.75 Credits $249.00 USD
Narcolepsy and Excessive Daytime Sleepiness in OSA: Strategies to Improving Outcomes
January 26, 2020
In this program, sleep experts Dr. Richard Bogan (Chair), Dr. Yves Dauvilliers, Dr. Kiran Maski, Dr. Paula Schweitzer, and Dr. Michael Thorpy assess traditional and new therapies for treating patients with narcolepsy and EDS in OSA.
CME 2.00 Credits
Narcolepsy in Children: Addressing the Challenges and Improving the Outcomes
January 04, 2020
In this program, pediatric sleep disorder experts Kiran Maski, MD, MPH; Judith Owens, MD, MPH, and Michael Strunc, MD will describe best practices in diagnosis and treatment of narcolepsy.
CME 1.50 Credits
Tailoring LDL-C-Lowering Therapy to Patient Cardiovascular Risk: Identifying Effective Strategies for Patients with Diabetes
November 30, 2019
In this program, a panel of experts will discuss the latest guidelines for managing LDL-C in patients with diabetes, interpret data with nonstatin, LDL-C-lowering therapies, describe improving access to PCSK9 inhibitors and tips for achieving earlier access,
No Credit Available
Using Narcolepsy Medications Wisely: Tips for Clinical Practice
October 16, 2019
Audio presentations on the considerations and treatment options for the management of Narcolepsy
No Credit Available
Narcolepsy in Children: Overcoming Barriers and Improving Outcomes
October 04, 2019
Narcolepsy in Children
No Credit Available
Reducing LDL-C and Cardiovascular Risk with Nonstatin Therapy: From Evidence to Practice
July 02, 2019
In this symposium, lipid experts Dr. Robert Giugliano, Dr. Marc Sabatine, and Dr. James Underberg will describe best practices for internists in managing LDL-C and reducing the risk for major cardiovascular events with the addition of nonstatin therapy.
No Credit Available
Cardiovascular Outcome Trials and Expert Consensus Decision Pathways: Interpreting the Evidence with Nonstatin Therapies
May 21, 2019
No Credit Available
Non-Statin Therapy for LDL-Cholesterol Reduction in Primary and Secondary Prevention
May 21, 2019
No Credit Available
Managing LDL-C to Reduce Cardiovascular Disease Risk: Defining Best Clinical Practice
April 22, 2019
In this program, an expert faculty will discuss the evidence and recommendations for managing LDL-C in patients with ASCVD, familial hypercholesterolemia (FH), diabetes, and those at increased cardiovascular risk without ASCVD.
No Credit Available